On March 23, 2023, the NCCRT convened over 350 participants at its eighth annual Colorectal Cancer Awareness Month Webcast to celebrate national achievements and to share the latest state of the field updates. Participants heard from Steven Itzkowitz, MD and Robert Smith, PhD, NCCRT co-chairs; Lisa Richardson, MD, MPH, Director, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention; Rebecca Siegel, Senior Scientific Director, Surveillance Research, American Cancer Society; and other special guests. The webcast also featured our 2023 80% in Every Community National Achievement Awards winners.
Following are several relevant links referenced in the webcast:
- Colorectal Cancer Facts & Figures
- NYTimes article on early-age onset CRC
- CDC’s Colorectal Cancer Control Program (CRCCP)
- Learn more about United in Blue (Fight CRC)
- Find a health center (HRSA)
- Mailed FIT Implementation Guide (NACDD)
- Journal of General Internal Medicine publication on results from the Dell Medical School and CommUnityCare partnership
- 2022 Steps for Increasing Colorectal Cancer Screening Rates: A Manual for Primary Care Practices
- Learn more about the ACS NCCRT’s 2023 awardees
- Learn more about ACS NCCRT membership
- 80% in Every Community Strategic Plan
- Follow us on Twitter and on LinkedIn
Explore More

Blue Star Conversation: April 15, 2025
This Blue Star Conversation covered, "Modeling the Impact of Colorectal Cancer Screening and Timely Follow-Up Colonoscopy: Recent Data from the Cancer Intervention and Surveillance Modeling Network (CISNET)"

ACS Webinar: Cancer Prevention and Screening for Community Health Centers
This webinar focused on health centers and covered the current state of colorectal cancer, the urgent need for screening patients age 45-55, and a review of tools and resources available.

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening
This revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer.